|
Gilead Sciences Inc (GILD) |
|
|
|
| |
Gilead Sciences Inc Income Statement Quarterly
GILD
|
Select the Financial Report: |
Period: |
Fiscal Year: |
|
|
|
|
INCOME STATEMENT
(Quarterly GAAP In millions $) |
(Jun 30 2024)
II. Quarter |
(Mar 31 2024)
I. Quarter |
(Dec 31 2023)
IV. Quarter |
(Sep 30 2023)
III. Quarter |
(Jun 30 2023)
II. Quarter |
| Revenue From Contract With Customer Excluding Assessed Tax |
6,954.00 |
6,686.00 |
|
7,051.00 |
6,599.00 |
| Royalty Contract and Other Revenue |
- |
- |
|
- |
- |
| Total Revenue |
6,954.00 |
6,686.00 |
7,114.00 |
7,051.00 |
6,599.00 |
| Cost of Goods and Services Sold |
1,544.00 |
1,552.00 |
2,090.00 |
1,565.00 |
1,442.00 |
| Gross
Profit |
5,410.00 |
5,134.00 |
5,024.00 |
5,486.00 |
5,157.00 |
| Selling, Administration, Marketing |
1,377.00 |
1,375.00 |
1,607.00 |
1,315.00 |
1,849.00 |
| Depriciation & Amortization |
- |
- |
- |
- |
- |
| Research & development |
1,351.00 |
1,520.00 |
2,373.00 |
1,457.00 |
1,407.00 |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) |
- |
2,430.00 |
50.00 |
- |
- |
| Other operatinig exp. /-income |
-199.00 |
4,131.00 |
-618.00 |
91.00 |
236.00 |
| Special items |
- |
- |
- |
- |
- |
| Interest Expense Nonoperating |
237.00 |
- |
- |
- |
- |
| Total operating costs including COS |
4,310.00 |
11,008.00 |
5,502.00 |
4,428.00 |
4,934.00 |
| Operating income/-loss
|
2,644.00 |
-4,322.00 |
1,612.00 |
2,623.00 |
1,665.00 |
|
Other Deductions / - Income |
| Interest expense |
- |
254.00 |
252.00 |
232.00 |
230.00 |
| Interest income |
- |
- |
- |
- |
- |
| Net interest expense/-income |
- |
254.00 |
252.00 |
232.00 |
230.00 |
| Loss/ -Gain on Investment |
- |
- |
- |
- |
- |
| Income from affiliates |
- |
- |
- |
- |
- |
| Sale of Assets |
- |
- |
- |
- |
- |
| Financing Loss/ -Income |
- |
- |
- |
- |
- |
| Other loss/ -income |
591.00 |
-90.00 |
-293.00 |
73.00 |
-153.00 |
| Total costs & expenses |
4,901.00 |
11,172.00 |
5,461.00 |
4,733.00 |
5,011.00 |
| Income /-loss before income taxes |
2,053.00 |
-4,486.00 |
1,653.00 |
2,318.00 |
1,588.00 |
| Income taxes expenses/-benefit |
438.00 |
-315.00 |
236.00 |
146.00 |
549.00 |
| Income after income taxes |
1,614.00 |
-4,170.00 |
1,417.00 |
2,172.00 |
1,039.00 |
| Net income/-loss
of other equity |
-1.00 |
1.00 |
- |
- |
- |
| Income/-loss
from cont. Ops. |
1,614.00 |
-4,170.00 |
1,417.00 |
2,172.00 |
1,039.00 |
| Accounting change |
- |
- |
- |
- |
- |
| Discontinued operations |
- |
- |
- |
- |
- |
| Extraordinary items |
- |
- |
- |
- |
- |
| Net Income/-loss |
1,614.00 |
-4,170.00 |
1,417.00 |
2,172.00 |
1,039.00 |
| Noncontrolling interests |
- |
- |
12.00 |
8.00 |
6.00 |
| Prefered dividends |
- |
- |
- |
- |
- |
| Other |
- |
- |
- |
- |
- |
| Income/-loss to shareholder |
1,614.00 |
-4,170.00 |
1,430.00 |
2,180.00 |
1,045.00 |
| EBIT |
2,053.00 |
-4,232.00 |
1,905.00 |
2,550.00 |
1,818.00 |
| EBITD |
2,151.00 |
-4,138.00 |
1,996.00 |
2,636.00 |
1,901.00 |
| EBITDA |
2,747.00 |
-3,542.00 |
2,593.00 |
3,234.00 |
2,499.00 |
| Per
Share (GAAP Quarterly, in $) |
(Jun 30 2024)
II. Quarter |
(Mar 31 2024)
I. Quarter |
(Dec 31 2023)
IV. Quarter |
(Sep 30 2023)
III. Quarter |
(Jun 30 2023)
II. Quarter |
| Basic EPS (excl. extra
items) |
1.29 |
-3.34 |
1.14 |
1.75 |
0.84 |
| Extraordinary items |
0.00 |
0.00 |
-0.01 |
0.00 |
0.00 |
| Basic Net EPS |
1.29 |
-3.34 |
1.15 |
1.75 |
0.84 |
| Basic shares outstanding (Mill.
of Units) |
1,247.00 |
1,247.00 |
1,247.00 |
1,248.00 |
1,249.00 |
| EPS other shares |
- |
- |
- |
- |
- |
| Diluted Net EPS |
1.29 |
-3.34 |
1.14 |
1.73 |
0.83 |
| Diluted average shares (Mill.
of Units) |
1,251.00 |
1,247.00 |
1,258.89 |
1,257.00 |
1,258.00 |
| Dividend per share |
0.777 |
0.794 |
0.749 |
0.758 |
0.75 |
|
|
